Non-Prescription (OTC) / ALKACITRAT

Therapeutic indications: Indigestion (slow digestion, bloating).
Posology and method of administration: Oral use.
Dosage: For adults and children over 15 years: 1 to 3 tablets daily.
Method of administration : The effervescent tablets are dissolved in half a glass of water. ALKACITRAT is taken before or after meals. The duration of treatment is limited to 7 days.
Contraindications : Hypersensitivity to the active substance or to any of the excipients listed
Special warnings and precautions for use : ALKACITRAT contains 16.66 mmol sodium (or 383.2 mg) per dose. Patients on a controlled sodium diet should be considered.
Interactions with other medicines and forms of interaction : The data available to date do not indicate the existence of clinically significant interactions.
Fertility, pregnancy and lactation : Avoid during pregnancy and lactation due to lack of clinical and experimental data.
Effects on ability to drive and use machines : ALKACITRAT does not appear to affect the ability to drive and use machines.
Unwanted actions : Allergic reactions (urticaria, angioedema and rash) have been reported.
Overdose : No cases of overdose have been reported.
Pharmacodynamic properties : Pharmacotherapeutic group: Digestive and metabolic products, ATC code: A16AA06. Betaine citrate is traditionally used to treat indigestion symptoms. This information is based solely on tradition and years of experience.
List of excipients : Mannitol, Citric acid anhydrous, Sodium bicarbonate, Raspberry flavor, Sodium saccharin, Sodium benzoate, Polyethylene glycol 6000, Starch pregelatinized.
Licence number : 89058 / 10.10.2017….